Overview Financials News + Filings Key Docs Charts Ownership Insiders |
RESPIRONICS INC (RESP)
|
Add to portfolio |
|
|
Price: |
$51.60
| | Metrics |
OS: |
74.0
|
M
| |
13
|
% ROE
|
Market cap: |
$3.82
|
B
| |
56
|
% ROIC
|
Net cash:
|
$269
|
M
| |
$3.64
|
per share
|
EV:
|
$3.55
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$521
|
M
| |
6.8
|
x EV/EBITDA
|
EBIT
|
$437
|
M
| |
8.1
|
x EV/EBIT
|
EPS |
$1.73
| |
29.8
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-07 | Jun-30-06 | Jun-30-05 | Jun-30-04 | Jun-30-03 | Jun-30-02 | Jun-30-01 |
Revenues | 1,195.0 | 1,046.1 | 911.5 | 759.5 | 629.8 | 494.9 | 422.4 |
Revenue growth | 14.2% | 14.8% | 20.0% | 20.6% | 27.3% | 17.2% | |
Cost of goods sold | 555.8 | 473.3 | 413.2 | 356.6 | 310.4 | 260.8 | 224.1 |
Gross profit | 639.2 | 572.9 | 498.3 | 402.9 | 319.4 | 234.1 | 198.4 |
Gross margin | 53.5% | 54.8% | 54.7% | 53.0% | 50.7% | 47.3% | 47.0% |
Research and development | 65.9 | 59.0 | 45.6 | 29.5 | 24.0 | 17.3 | 15.3 |
General and administrative | 164.3 | 149.5 | 123.0 | 100.2 | 83.7 | 60.7 | 50.1 |
EBITA | 409.0 | 364.4 | 329.6 | 279.3 | 218.7 | 160.2 | 67.6 |
EBITA margin | 34.2% | 34.8% | 36.2% | 36.8% | 34.7% | 32.4% | 16.0% |
Amortization of intangibles | | | | 6.1 | 7.7 | 5.7 | 5.2 |
EBIT | 409.0 | 364.4 | 329.6 | 273.2 | 211.0 | 154.5 | 62.4 |
EBIT margin | 34.2% | 34.8% | 36.2% | 36.0% | 33.5% | 31.2% | 14.8% |
Pre-tax income | 174.8 | 159.2 | 135.7 | 105.2 | 74.9 | 64.0 | 55.9 |
Income taxes | 52.5 | 59.3 | 51.4 | 40.2 | 28.3 | 25.6 | 22.3 |
Tax rate | 30.0% | 37.3% | 37.8% | 38.2% | 37.8% | 40.0% | 40.0% |
Net income | 122.3 | 99.9 | 84.4 | 65.0 | 46.6 | 38.4 | 33.6 |
Net margin | 10.2% | 9.5% | 9.3% | 8.6% | 7.4% | 7.8% | 7.9% |
|
Diluted EPS | $1.66 | $1.36 | $1.17 | $0.92 | $0.68 | $1.20 | $1.09 |
Shares outstanding (diluted) | 73.8 | 73.6 | 72.3 | 70.6 | 68.7 | 32.0 | 30.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|